AIMC Topic: Drug Discovery

Clear Filters Showing 471 to 480 of 1550 articles

Designing molecules with autoencoder networks.

Nature computational science
Autoencoders are versatile tools in molecular informatics. These unsupervised neural networks serve diverse tasks such as data-driven molecular representation and constructive molecular design. This Review explores their algorithmic foundations and a...

Drug discovery: In silico dry data can bypass biological wet data?

British journal of pharmacology
The recent and extraordinary increase in computer power, along with the availability of efficient algorithms based on artificial intelligence, has prompted a large number of inexperienced scientists to challenge the complex and yet competitive world ...

CLOOME: contrastive learning unlocks bioimaging databases for queries with chemical structures.

Nature communications
The field of bioimage analysis is currently impacted by a profound transformation, driven by the advancements in imaging technologies and artificial intelligence. The emergence of multi-modal AI systems could allow extracting and utilizing knowledge ...

Artificial intelligence and machine learning for clinical pharmacology.

British journal of clinical pharmacology
Artificial intelligence (AI) will impact many aspects of clinical pharmacology, including drug discovery and development, clinical trials, personalized medicine, pharmacogenomics, pharmacovigilance and clinical toxicology. The rapid progress of AI in...

STAGAN: An approach for improve the stability of molecular graph generation based on generative adversarial networks.

Computers in biology and medicine
With the wide application of deep learning in Drug Discovery, deep generative model has shown its advantages in drug molecular generation. Generative adversarial networks can be used to learn the internal structure of molecules, but the training proc...

Deep Generative Models in Drug Molecule Generation.

Journal of chemical information and modeling
The discovery of new drugs has important implications for human health. Traditional methods for drug discovery rely on experiments to optimize the structure of lead molecules, which are time-consuming and high-cost. Recently, artificial intelligence ...

Artificial intelligence: Machine learning approach for screening large database and drug discovery.

Antiviral research
Recent research in drug discovery dealing with many faces difficulties, including development of new drugs during disease outbreak and drug resistance due to rapidly accumulating mutations. Virtual screening is the most widely used method in computer...

Computational methods in glaucoma research: Current status and future outlook.

Molecular aspects of medicine
Advancements in computational techniques have transformed glaucoma research, providing a deeper understanding of genetics, disease mechanisms, and potential therapeutic targets. Systems genetics integrates genomic and clinical data, aiding in identif...

Automation to Enable High-Throughput Chemical Proteomics.

Journal of proteome research
Chemical proteomics utilizes small-molecule probes to covalently engage with their interacting proteins. Since chemical probes are tagged to the active or binding sites of functional proteins, chemical proteomics can be used to profile protein target...

Extracting medicinal chemistry intuition via preference machine learning.

Nature communications
The lead optimization process in drug discovery campaigns is an arduous endeavour where the input of many medicinal chemists is weighed in order to reach a desired molecular property profile. Building the expertise to successfully drive such projects...